Objective Grundium´s team of former leading innovators from Nokia and Microsoft have created a disruptive technology that enables to launch the world´s first portable and low-cost digital scanning microscope for clinical and research use.Today, digital pathology is at the verge of major breakthrough and it is regarded as one of the key enabling technologies in future medicine, forming a €5 billion market by 2023. The market for digital pathology tools is growing 12% annually and reaches €700 million in few years. Digital pathology is seen as the solution to the global shortage of pathologists and growing need for tissue analysis.Only digitally scanned slides and software-assisted tools can reveal the hidden patterns of various pathologies (e.g. cancer) that are so far left invisible to even most trained experts. However, among the potential users (clinics, labs, research), 80% still have no tools for scanning the traditional glass slides and they must still rely on manual methods that are error-prone and enable to rely on only the locally available pathology expertise and capacity.Today, the main implementation barrier is the high cost of the available scanning devices. State-of-the-art solutions cost up to 200k€ and are stationary due to their large size. Thus, they are mainly used in larger hospitals where the bigger diagnostic throughput makes them somewhat cost-efficient.The biggest unaddressed markets segments are small/medium clinics and pathology labs. Our addressable markets include more than 10,000 such clinics/labs just in EU and North-America.The SME-project enables us to finalize our development, acquire certifications, conduct pilots with leading European hospitals and pathology labs and start the commercialization phase.By 2022, we are the leaders in desktop scanning microscopes and have enabled the faster and more widespread transition to digital pathology era globally. Fields of science natural sciencescomputer and information sciencessoftwaresoftware developmentnatural sciencesphysical sciencesopticsmicroscopyengineering and technologymaterials engineeringmedical and health sciencesbasic medicinepathologymedical and health sciencesclinical medicineoncologycervical cancer Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-SMEInst-2018-2020-2 Funding Scheme SME-2 - SME instrument phase 2 Coordinator GRUNDIUM OY Net EU contribution € 1 950 375,00 Address HERMIANKATU 6-8D 33720 TAMPERE Finland See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Manner-Suomi Länsi-Suomi Pirkanmaa Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 2 786 250,00
